Hikma Pharmaceuticals PLC (HIK.L)
Hikma Pharmaceuticals PLC
1 New Burlington Place
London W1S 2HR
United Kingdom
44 20 7399 2760
https://www.hikma.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 9,100
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Engineer Said Samih Taleb Darwazah | Executive Chairman | 2.23M | N/D | 1957 |
| Mr. Riad Ali Mishlawi | CEO & Director | 879.03k | N/D | 1964 |
| Mr. Mazen Samih Taleb Darwazah | Executive Vice Chairman & President of MENA | 1.83M | N/D | 1958 |
| Mr. Khalid Waleed Hosny Al Nabilsi | Chief Financial Officer | N/D | N/D | 1972 |
| Patricia Bousfield | Chief Information Officer | N/D | N/D | N/D |
| Mr. Guy Featherstone | Associate Director of Investor Relations | N/D | N/D | N/D |
| Mr. Samuel Park | General Counsel | N/D | N/D | N/D |
| Mr. Bassam Wael Rushdi Kanaan CFA, CPA | Executive Vice President of Corporate Development and M&A | N/D | N/D | 1965 |
| Mr. Hussein Omar Arkhagha | Chief People Officer | N/D | N/D | N/D |
| Ms. Susan Ringdal | Executive Vice President of Strategic Planning & Global Affairs | N/D | N/D | N/D |
Descripción
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Gestión corporativa
La calificación ISS Governance QuickScore de Hikma Pharmaceuticals PLC a partir del 1 de mayo de 2024 es 3. Las puntuaciones principales son Auditoría: 6; Junta: 5; Derechos del accionista: 1; Compensación: 1.
